Rare diseases
Investigational molecules
Locations
239 conditions with trials, the busiest first
357 trials across Europe, recruiting first
Advanced hepatocellular carcinoma patients: assessing atezolizumab drug combination and other treatment sequences
ItalyPhase 2 Study of Lirafugratinib in Patients with Previously Treated Unresectable Advanced Solid Tumors with FGFR2 Fusion (Excluding Cholangiocarcinoma)
FranceLow‑dose human serum albumin versus standard dose during large‑volume paracentesis in patients with liver cirrhosis
The NetherlandsPhase 2 Study of Durvalumab + Tremelimumab with Lenvatinib vs Durvalumab + Tremelimumab Alone in Patients with Unresectable Hepatocellular Carcinoma
ItalySafety and Efficacy of TSRA-196 (rnaivt9315 and rnacs24757) in Adults with Lung or Liver Disease due to Alpha‑1 Antitrypsin Deficiency
IrelandDB-1311 in Combination with BNT327 or DB-1305 for Patients with Advanced or Metastatic Solid Tumors
FranceA study to evaluate the safety and effectiveness of PF-08634404 and ipilimumab in adults with advanced or spreading liver cancer
FranceA study to evaluate if atorvastatin prevents gallstones in patients undergoing bariatric surgery
The NetherlandsA study to evaluate the safety and effectiveness of AZD9793 in adults with advanced or metastatic liver cancer
SpainA study to evaluate the safety and effectiveness of MRNA3771 and GRNA1599 in adults with chronic hepatitis B
FranceStudy of Fecal Microbiota Transplantation Compared to Sham Treatment for Patients with Primary Sclerosing Cholangitis
FranceA Study Using Indocyanine Green Fluorescence Imaging to Help Surgeons Better Identify Tumor Edges During Cancer Surgery in Patients with Solid Tumors
The NetherlandsThe therapies tested most often in Hepatobiliary disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
